Topics and Expertise: Genentech

UCSF's Small Molecule Discovery Center (SMDC) announced on February 18, 2010 that it has signed its first major industry partnership agreement since the SMDC was founded in 2005. The agreement is with Genentech, Inc. to discover and develop drug candidates for neurodegenerative diseases.

Susan Desmond-Hellmann, MD, MPH, pioneering cancer researcher and biotechnology industry executive who most recently served as president of product development for the biotechnology company, Genentech, Inc., was named chancellor of UCSF on May 7, 2009 by the University of California Board of...